| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443980 | European Journal of Cancer | 2013 | 11 Pages |
Abstract
Double negative hormone receptor status in endometrial cancer curettage independently predicts lymph node metastasis and poor prognosis in a prospective multicentre setting. Implementing hormone receptor status to improve risk-stratification for selecting patients unlikely to benefit from lymphadenectomy seems justified.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jone Trovik, Elisabeth Wik, Henrica M.J. Werner, Camilla Krakstad, Harald Helland, Ingrid Vandenput, Tormund S. Njolstad, Ingunn M. Stefansson, Janusz Marcickiewicz, Solveig Tingulstad, Anne C. Staff, MoMaTEC study group MoMaTEC study group,